[1] | Marona, H.R.N.; Schapoval, E.E.S. J Pharm Biomedical Analysis, Amsterdam, 20:413-7, 1999. |
[2] | Marona, H.R.N.; Schapoval, E.E.S. J. Pharm. Biomedical Anal., Amsterdam, 26(3):501-4, 2001. |
[3] | Marona, H.R.N.; Schapoval, E.E.S. European J Pharmaceutics and Biopharmaceutics, Amsterdam, 52(2):227-9, 2001. |
[4] | Griggs, D.J.; Marona, H.R.N.; Piddock, L.J.V. J Antimicrobial Chemother., Oxford, v.51, p.1403-1407, 2003. |
[5] | Salgado, H.R.N., Oliveira, C.L.C.G. Die Pharmazie, Eschborn, v.60, n.4, p.263-264, 2005. |
[6] | Salgado, H.R.N.; Roncari, A.F.F. Acta Pharmacologica Sinica, v.40, n.1, p.544-549, 2005. |
[7] | Salgado, H.R.N.; Lopes, C.C.G.O. J AOAC Int., v.89, n.3, p.642-645, 2005. |
[8] | Mourão, S.C.; Costa, P.I.; Salgado, H.R.N.; Gremião, M.P.D. Int. J. Pharmaceutics, v.295, p.157-162, 2005. |
[9] | Salgado, H.R.N.; Lucchesi, M.B.B.; Lopes, C.C.G.O. J Pharm Biomedical Anal., 40:443-6, 2006. |
[10] | Salgado, H.R.N.; Lopes, C.C.G.O. J. AOAC Int., v.89, n.3, p.642-645, 2006. |
[11] | Gomes, G.C.; H.R.N. Salgado. J. AOAC Int., v.89, n.4, p.1077-9, 2006. |
[12] | Tozo, G.C.G.; Salgado, H.R.N. J. AOAC Int., v. 89, n.5, 1305-7, 2006 |
[13] | Salgado, H.R.N.; Tozo, G.C.G. J AOAC Int., v.90, n.2, p.452-455, 2007. |
[14] | Moreno, A.H.; Salgado, H.R.N. J AOAC Int., v.90, n.5, p.1379-82 , 2007. |
[15] | Moreno, A.H.; Salgado, H.R.N. J AOAC, 91(4): 739-43, 2008. |
[16] | Moreno, A.H.; Salgado, H.R.N. Analytical Letters, v.41, n.12, p.2143-52 , 2008. |
[17] | Moreno, A.H.; Salgado, H.R.N. J. AOAC International, 92(3):820-3, 2009. |
[18] | Lopes, C.C.G.O.; Salgado, H.R.N. Chromatographia, 69:129-133, 2009. |
[19] | Cazedey, E.C.L.; Perez, D.P.; Perez, J.P.; Salgado, H.R.N. Chromatographia, 69:241-4, 2009. |
[20] | Bonfilio, R.; Araújo, M.B; Salgado, H.R.N. Talanta, 80(1):236-41, 2009. |
[21] | Lucinda-Silva, R.M.; Salgado, H.R.N.; Evangelista, R.C. Carbohydrate Polymers, 81:260-268, 2010. 10.1016/j.carbpol.2010.02.016 |
[22] | Chorilli, M.; Leonardi, G.R.; Nascimento, G.G.F.; Salgado, H.R.N.; Scarpa, M.V. J. AOAC Int. 2010 |
[23] | Silva, L.M.; Salgado, H.R.N. Tigecycline: a review of properties, applications and analytical methods. Therapeutic Drug Monitoring. in press. 10.1097/FTD.0b013e3181dda54f |
[24] | Fiorentino, F.A.M.; Corrêa, M.A.; Salgado, H.R.N. Critical Reviews in Analytical Chemistry, v.40, p.1-13, 2010. DOI: 10.1080/10408340903232010. ISSN: 1040-8347. |
[25] | Bonfilio, R.; Araújo, M.B; Salgado, H.R.N. Therapeutic Drug Monitoring. In press |
[26] | Lopes, C.C.G.O.; Salgado, H.R.N. Talanta. v.82, n.3, p.918-922, 2010. doi:10.1016/j.talanta.2010.05.056 |
[27] | Chorilli, M.; Leonardi, G.R.; Nascimento, G.G.F.; Salgado, H.R.N. J AOAC Int, v.94, n.1, p.118-127, 2011. |
[28] | Vieira, D.C.M.; Salgado, H.R.N. Journal of Chromatographic Science, v.49, p.508-511, 2011. |
[29] | Fiorentino, F.A.M.; Chorilli, M.; Salgado, H.R.N. Analytical Methods, v.3, p.790-798, 2011. DOI: 10.1039/C0AY00597E. ISSN 1759-9660. |
[30] | Chorilli, M.; Bonfilio, R.; R.S. Chicarelli, Salgado, H.R.N.. Analytical Methods, v.3, n.4, p.985-990, 2011. DOI: 10.1039/C0AY00598C. |
[31] | Corrêa, J.C.R.; Salgado, H.R.N..Critical Reviews in Analytical Chemistry, v.41, n.2, p.270-279, 2011. ISSN: 1040-8347 print/1547-6510 online DOI: 10.1080/10408347.2011.558924 |
[32] | Bonfilio, R.; Peres, C.; C.R.T. Tarley; Araújo, M.B.; Salgado, H.R.N. J. AOAC. Int., 2011. In press |
[33] | Cazedey, E.C.L.; Othman, A.; Garg, G.; Salgado, H.R.N. Current Pharm Analysis, 2011. In press |
[34] | Moreno, A.H.; Salgado, H.R.N. Development and validation of the quantitative analysis of ceftazidime in powder for injection by infrared spectroscopy. Physical Chemistry, 2011. In press ID: 102200007 DOI: 10.5923/j.pc.20110101.01 |